Overview

The Oral Contraceptive Pill for Premenstrual Worsening of Depression

Status:
Completed
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
To determine if augmentation with the oral-contraceptive pill containing drospirenone and ethinyl estradiol is more effective than placebo in the treatment of premenstrual breakthrough of depression.
Phase:
N/A
Details
Lead Sponsor:
Massachusetts General Hospital
Collaborator:
Bayer
Treatments:
Contraceptive Agents
Contraceptives, Oral
Contraceptives, Oral, Combined
Drospirenone
Drospirenone and ethinyl estradiol combination
Estradiol
Estradiol 17 beta-cypionate
Estradiol 3-benzoate
Estradiol valerate
Ethinyl Estradiol
Polyestradiol phosphate